IBI3011 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

149 results for “IBI3011”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011

64 participants · First posted Dec 19, 2025

IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

250 participants · First posted May 16, 2025

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

250 participants · First posted Apr 5, 2024

Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO

50 participants · First posted Sep 3, 2025

A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease

91 participants · First posted Nov 13, 2023

The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

136 participants · First posted Feb 20, 2020

A Study of IBI311 in Healthy Volunteers

28 participants · First posted Jul 29, 2022

A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye Disease

111 participants · First posted Aug 8, 2025

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

64 participants · First posted Sep 3, 2025

Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.

96 participants · First posted Sep 3, 2025

Page 1 of 14